Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
about
Patient perspectives on fluticasone-vilanterol versus other corticosteroid combination products for the treatment of asthmaSpotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapySafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial.Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects.Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroidsEfficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination.Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial.Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trialsThe EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trialThe ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial.Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trialIntegrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjectsOnce-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.A review of mometasone furoate / formoterol in the treatment of asthma.Fluticasone furoate/vilanterol: a review of its use in patients with asthma.Emerging corticosteroid agonists for the treatment of asthma.The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma.Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trial.Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.Measurement properties of an asthma symptom and rescue medication use diary.Authors' reply to 'Safety and tolerability of fluticasone furoate/vilanterol'.Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.
P2860
Q26743444-DE50E814-E6BC-4AEA-B1AC-EEC53D825FA5Q28074802-D0C6031C-2026-41D1-AAD5-22A07C61F105Q30409095-1E848962-04B4-4902-A54A-6C978DDAAFFCQ30430396-F72EC838-C643-48B9-8FD5-648DA8804B98Q33749702-7D29225F-818C-46D4-B176-C7B3C490FC4AQ33937441-D9E42257-6F8D-4480-B039-03EF993D9D74Q34470553-6B564489-36F3-4D9D-8314-CB361576197CQ34636952-7D54653C-CC27-43F6-9380-FBA8CFDB0106Q35086014-52FA77E9-B5B7-4BD9-BEBF-8E41C25D376EQ35878541-7B1AEBD3-24ED-46D9-802E-9D6D4F89941FQ36288980-2D0ED66D-5B21-4771-87D3-7C8B975EA076Q36355311-2D166776-1B55-4D11-ABFE-CDE35B14D3A8Q36388517-F5EEBBD5-5AC4-4D14-9A1C-0624432D7678Q36876695-92F39E2D-B8BD-4917-ABD9-0880F648812CQ37209570-C21B1045-10A1-4F70-8D48-D1658C2C5983Q37436410-AFC46769-C3C2-4FED-88DB-F61011B8DF62Q37610412-D32C759A-0C46-4F37-B8B2-1051D80EE2D9Q37635200-24B76A1C-61D4-4C2F-91F5-F9E51650367BQ37658668-B4E94C4A-A423-4576-A50F-9EE8C41A5293Q38077842-0B611626-228B-410B-95B4-AB21B2251A04Q38342870-E120AA40-C2EA-488D-8779-82611560BE76Q38537176-5D51443E-75C0-4B8D-B969-B62701E7CB1AQ38669520-98B0CA44-54FF-4F2E-AA79-B493BA1C284DQ38707759-F93AED64-AFE8-458E-8210-EC2E07B3E143Q38851423-B41EEA96-2C68-4165-A389-080C276E1D5FQ38909886-63D3B4B3-D3A6-4C43-90D4-B94AC1470781Q38947467-DD7EB1AD-988C-49D9-8C36-4E5E7317CDBFQ39810415-C2F75F99-0773-42DD-A526-00983B81C483Q40624707-006DE5DE-EE7B-4BDB-A594-7F5599E0B835Q51671642-0A767381-F2BA-4BCD-A934-11535D0CA90CQ51698477-DD049FE2-834F-46FA-8710-753A427404B7Q54644123-453D5B86-A010-45F7-9D3A-D84286F1C6B9Q55057134-4F938657-FE61-400A-BE1E-26230EA4AB86
P2860
Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2012
@uk
name
Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
@en
Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
@nl
type
label
Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
@en
Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
@nl
prefLabel
Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
@en
Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
@nl
P2093
P50
P1433
P1476
Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
@en
P2093
Angela M. Davis
Brett Haumann
Eric D. Bateman
Hilary Medley
Loretta Jacques
P304
P356
10.1016/J.RMED.2012.01.004
P577
2012-05-01T00:00:00Z